
Emma Pinzón
Emma Pinzón is the president of the National Federation of Associations of Critical, Chronic, and Degenerative Diseases in Panama. She has been an advocate for patients with severe health conditions, emphasizing the importance of access to essential medications. Recently, she highlighted the significance of a centralized tender by the Caja de Seguro Social (CSS) to acquire 16 critical medications, ensuring that they reach patients who need them most.
Not in the pool (under ¢1).
Recent news mentions
Emma Pinzón, president of the National Federation of Associations of Critical, Chronic and Degenerative Diseases, stated that this purchase 'guarantees access to essential treatments'.
Licitación por $84.6 millones para la compra de medicinas atrae el interés de 30 empresas
Emma Pinzón expressed her concern about the lack of public bidding for medication acquisition.
Instalan comisión para garantizar suministro de medicamentos en 2026Emma Pinzón recognized the advances in the reduction of surgical delays.
Seguro Social destina $8,122 millones para 2026 y apuesta por plataformas digitales en saludEmma Pinzón alerted about the recent reduction of the budget of the Ministry of Health and warned that this decision puts the lives of thousands of patients at risk.
Pacientes crónicos rechazan recorte presupuestario en salud, alertan desabastecimientoEmma Pinzón, president of the National Federation of Associations of Critical, Chronic, and Degenerative Diseases, supports the unification of the healthcare system.
CSS amplía su cobertura alimentaria hospitalaria con más de 9,000 comidas diarias, ahora incluye al HSTEmma Pinzón emphasized the importance of patients attending their medical appointments amidst the current insecurity in the country.
Pacientes y servicios de salud, entre los más impactados por bloqueos y cierresEmma Pinzón, president of the National Federation of Associations of Critical, Chronic, and Degenerative Diseases, indicated that this purchase is of great importance for the insured population.
CSS avanza en licitación centralizada de medicamentos para enfermedades crónicas y raras








